| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1996;62:1759-1764
© 1996 The Society of Thoracic Surgeons
Cardiac Intensive Care Unit and Department of Cardiology, Children's Hospital, and Departments of Pediatrics and Anesthesia, Harvard Medical School, Boston, Massachusetts
Accepted for publication June 20, 1996.
Background. We describe the hemodynamic response to initiation and withdrawal of inhaled nitric oxide (NO) in infants with pulmonary hypertension after surgical repair of total anomalous pulmonary venous connection.
Methods. Between January 1, 1992, and January 1, 1995, 20 patients underwent repair of total anomalous pulmonary venous connection. Nine patients had postoperative pulmonary hypertension and received a 15-minute trial of inhaled NO at 80 parts per million. Five of these patients received prolonged treatment with NO at 20 parts per million or less.
Results. Mean pulmonary artery pressure decreased from 35.6 ± 2.4 to 23.7 ± 2.0 mm Hg (mean ± standard error of the mean) (p = 0.008), and pulmonary vascular resistance decreased from 11.5 ± 2.0 to 6.4 ± 1.0 U•m2 (p = 0.03). After prolonged treatment with NO, pulmonary artery pressure increased transiently in all patients when NO was discontinued.
Conclusions. After operative repair of total anomalous pulmonary venous connection, inhaled NO selectively vasodilated all patients with pulmonary hypertension. Withdrawal of NO after prolonged inhalation was associated with transient rebound pulmonary hypertension that dissipated within 60 minutes. Appreciation of rebound pulmonary hypertension may have important implications for patients with pulmonary hypertensive disorders when interruption of NO inhalation is necessary or when withdrawal of NO is planned.
This article has been cited by other articles:
|
|
 |
|
  S. Kumar, X. Sun, S. Sharma, S. Aggarwal, K. Ravi, J. R. Fineman, and S. M. Black GTP cyclohydrolase I expression is regulated by nitric oxide: role of cyclic AMP Am J Physiol Lung Cell Mol Physiol, August 1, 2009; 297(2): L309 - L317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Grimminger, G. Weimann, R. Frey, R. Voswinckel, M. Thamm, D. Bolkow, N. Weissmann, W. Muck, S. Unger, G. Wensing, et al. First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension Eur. Respir. J., April 1, 2009; 33(4): 785 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Ghofrani and F. Grimminger Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy Eur. Respir. Rev., March 1, 2009; 18(111): 35 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cai, Z. Su, Z. Shi, Y. Zhou, Z. Xu, Z. Xu, and Y. Yang Nitric Oxide and Milrinone: Combined Effect on Pulmonary Circulation After Fontan-Type Procedure: A Prospective, Randomized Study Ann. Thorac. Surg., September 1, 2008; 86(3): 882 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Frey, W. Muck, S. Unger, U. Artmeier-Brandt, G. Weimann, and G. Wensing Single-Dose Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of the Soluble Guanylate Cyclase Stimulator BAY 63-2521: An Ascending-Dose Study in Healthy Male Volunteers J. Clin. Pharmacol., August 1, 2008; 48(8): 926 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nemoto, E. Umehara, T. Ikeda, T. Itonaga, and M. Komeda Oral Sildenafil Ameliorates Impaired Pulmonary Circulation Early After Bidirectional Cavopulmonary Shunt Ann. Thorac. Surg., May 1, 2007; 83(5): e11 - e13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Namachivayam, U. Theilen, W. W. Butt, S. M. Cooper, D. J. Penny, and L. S. Shekerdemian Sildenafil Prevents Rebound Pulmonary Hypertension after Withdrawal of Nitric Oxide in Children Am. J. Respir. Crit. Care Med., November 1, 2006; 174(9): 1042 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Stanley, L. G. Chicoine, T. L. Young, K. M. Reber, C. R. Lyons, Y. Liu, and L. D. Nelin Gene transfer with inducible nitric oxide synthase decreases production of urea by arginase in pulmonary arterial endothelial cells Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L298 - L306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Oishi, A. Grobe, E. Benavidez, B. Ovadia, C. Harmon, G. A. Ross, K. Hendricks-Munoz, J. Xu, S. M. Black, and J. R. Fineman Inhaled nitric oxide induced NOS inhibition and rebound pulmonary hypertension: a role for superoxide and peroxynitrite in the intact lamb Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L359 - L366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J.D. Griffiths and T. W. Evans Inhaled Nitric Oxide Therapy in Adults N. Engl. J. Med., December 22, 2005; 353(25): 2683 - 2695. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ng, S. J. Finney, R. Shulman, G. J. Bellingan, M. Singer, and P. A. Glynne Treatment of pulmonary hypertension in the general adult intensive care unit: a role for oral sildenafil? Br. J. Anaesth., June 1, 2005; 94(6): 774 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Rashid and D Ivy Severe paediatric pulmonary hypertension: new management strategies Arch. Dis. Child., January 1, 2005; 90(1): 92 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Ross, P. Oishi, A. Azakie, S. Fratz, R. K. Fitzgerald, M. J. Johengen, C. Harmon, K. Hendricks-Munoz, J. Xu, S. M. Black, et al. Endothelial alterations during inhaled NO in lambs with pulmonary hypertension: implications for rebound hypertension Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L27 - L35. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Maruyama, B. H. Jiang, K. Maruyama, M. Takata, and K. Miyasaka Prolonged Nitric Oxide Inhalation During Recovery From Chronic Hypoxia Does Not Decrease Nitric Oxide-Dependent Relaxation in Pulmonary Arteries Chest, December 1, 2004; 126(6): 1919 - 1925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Thelitz, J. M. Bekker, B. Ovadia, R. B. Stuart, M. J. Johengen, S. M. Black, and J. R. Fineman Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1285 - 1292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. K. Kelly, S. Wedgwood, R. H. Steinhorn, and S. M. Black Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase Am J Physiol Lung Cell Mol Physiol, May 1, 2004; 286(5): L984 - L991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Han, E. Qamirani, A. G. Nelson, D. R. Hyduke, G. Chaudhuri, L. Kuo, and J. C. Liao Regulation of nitric oxide consumption by hypoxic red blood cells PNAS, October 14, 2003; 100(21): 12504 - 12509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Miyaji, N. Nagata, T. Miyamoto, and K. Kitahori Combined therapy with inhaled nitric oxide and intravenous epoprostenol (prostacyclin) for critical pulmonary perfusion after the Fontan procedure J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 437 - 439. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Chen, H. He, E. F. Mondejar, and G. Hedenstierna Cyclooxygenase inhibitor blocks rebound response after NO inhalation in an endotoxin model Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H290 - H298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Shekerdemian, H. B. Ravn, and D. J. Penny Intravenous Sildenafil Lowers Pulmonary Vascular Resistance in a Model of Neonatal Pulmonary Hypertension Am. J. Respir. Crit. Care Med., April 15, 2002; 165(8): 1098 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chen, H. He, E. F. Mondejar, F. Freden, P. Wiklund, K. Alving, and G. Hedenstierna Endothelin-1 and nitric oxide synthase in short rebound reaction to short exposure to inhaled nitric oxide Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H124 - H131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. McMullan, J. M. Bekker, M. J. Johengen, K. Hendricks-Munoz, R. Gerrets, S. M. Black, and J. R. Fineman Inhaled nitric oxide-induced rebound pulmonary hypertension: role for endothelin-1 Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H777 - H785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Rimensberger, I. Spahr-Schopfer, M. Berner, E. Jaeggi, A. Kalangos, B. Friedli, and M. Beghetti Inhaled Nitric Oxide Versus Aerosolized Iloprost in Secondary Pulmonary Hypertension in Children With Congenital Heart Disease : Vasodilator Capacity and Cellular Mechanisms Circulation, January 30, 2001; 103(4): 544 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Weinberger, D. L. Laskin, D. E. Heck, and J. D. Laskin The Toxicology of Inhaled Nitric Oxide Toxicol. Sci., January 1, 2001; 59(1): 5 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Black, R. S. Heidersbach, D. M. McMullan, J. M. Bekker, M. J. Johengen, and J. R. Fineman Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1849 - H1856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Schulze-Neick, D. J. Penny, M. L. Rigby, C. Morgan, A. Kelleher, P. Collins, J. Li, A. Bush, E. A. Shinebourne, and A. N. Redington L-Arginine and Substance P Reverse the Pulmonary Endothelial Dysfunction Caused by Congenital Heart Surgery Circulation, August 17, 1999; 100(7): 749 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S Hayward, R. P Kelly, and P. S Macdonald Inhaled nitric oxide in cardiology practice Cardiovasc Res, August 15, 1999; 43(3): 628 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Sheehy, M. A. Burson, and S. M. Black Nitric oxide exposure inhibits endothelial NOS activity but not gene expression: a role for superoxide Am J Physiol Lung Cell Mol Physiol, May 1, 1998; 274(5): L833 - L841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Ivy, J. P. Kinsella, J. W. Ziegler, and S. H. Abman Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease J. Thorac. Cardiovasc. Surg., April 1, 1998; 115(4): 875 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Wessel, I. Adatia, L. J. Van Marter, J. E. Thompson, J. W. Kane, A. R. Stark, and S. Kourembanas Improved Oxygenation in a Randomized Trial of Inhaled Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn Pediatrics, November 1, 1997; 100(5): e7 - e7. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. FINER Inhaled nitric oxide in neonates Arch. Dis. Child. Fetal Neonatal Ed., September 1, 1997; 77(2): 81F - 84. [Full Text]
|
|
|
|
 |
|
 S. Wedgwood, D. M. McMullan, J. M. Bekker, J. R. Fineman, and S. M. Black Role for Endothelin-1-Induced Superoxide and Peroxynitrite Production in Rebound Pulmonary Hypertension Associated With Inhaled Nitric Oxide Therapy Circ. Res., August 17, 2001; 89(4): 357 - 364. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
